FSIPP has been a leader in promoting fair legislation, access to care and protecting reimbursement. We continue to educate payors, state officials and organizations regarding our area of expertise. We must take ownership of our speciality, promote well developed research and continue to expand our mission in the public and political arena.
To promote the development and practice of safe, high quality, cost-effective interventional pain management techniques for the diagnosis and treatment of pain and related disorders, and to ensure patient access to interventional pain medicine (or management) doctors and these treatments in the State of Florida.
May 10, 2018
Key Items You Need to Know
Effective Date: July 1, 2018
In an effort to address the opioid crisis impacting communities across the state, the Florida Legislature approved legislation last week that will have an impact on physicians and patients. All physicians practicing in Florida need to be aware of particular measures contained in the legislation that will impact you.
CLICK HERE FOR the complete FMA Newsletter.
BREAKING NEWS MARCH 29, 2018
CMS proposes to force patients off effective opioid doses without their physician's approval
Centers for Medicare and Medicaid Services (CMS) is proposing a limit on the amount of opioids a physician can prescribe to a patient. This limitation, that may take effect on Jan.1, 2019, would be unrelated to the patient's past experience or need. It would render pharmacists unable to fill prescriptions that CMS has defined as “high” or long-term dosages unless an appeal is approved. CMS defines long-term opioid therapy as opioid use for more than 90 consecutive days and high-dose usage as at least 90 mg morphine equivalent dosage (MED) per day. However, this definition has never received substantial scientific support. The history of dose investigation shows that opinions about what constitutes the appropriate amount of opioids have changed through the years. To begin, a paper published 15 years ago in the New England Journal of Medicine suggested most people do not benefit from opioids administered above 180 mg per day. This article ignited a heated debate. However, it focused on efficacy, not the risk of overdose or addiction at higher doses.
October 19, 2017
CMS has proposed severe cuts to reimbursement for Urine Drug Testing in 2018 and beyond.
You can help fight the cuts by emailing Seema Verma at CMS as indicated below. But you must do so by the close of business on Mon Oct 23.
The letter should be emailed to:
Use the Subject Line: Calendar Year (CY) 2018 Clinical Laboratory Fee Schedule (CLFS) Preliminary Determinations: Stakeholder Comments
May 8, 2017
PRESS RELEASE: Letter to Governor Rick Scott
Dear Governor Scott,
The Florida Society of Interventional Pain Physicians (FSIPP) would like to thank you for rising to the challenge of combatting the substance abuse and the opioid crisis in the State of Florida. Your unrelenting support of this problem has been much appreciated by the pain management physicians in our State. The task of controlling or eliminating this killer epidemic will not be easy, but we believe you can succeed. Thank you from the families, community, physicians, and others who have been impacted by this crisis.
May 2, 2017
REGARDING: CMS Webinar Series on the opioid epidemic, first of its kind. FSIPP suspects the perspective of CMS should be interesting and maybe even challenging. Click the link below to register for the Webinar.
The Center for Program Integrity will discuss CMS’ approach to combating the opioid epidemic, including priority areas which aim to:
To join the webinar, visit https://goto.webcasts.com/starthere.jsp?ei=1129992.
February 15, 2017
ALERT: Designee Access to E-FORCSE
On February 14, 2017, a designee of a prescriber or dispenser may have direct access to the controlled substance dispensing information in the E-FORCSE® database by registering on the E-FORCSE® secure web portal.
E-FORCSE staff will be hosting two webinars regarding the implementation of designee access, as outlined here.
January 20, 2017
Level II Office Based Florida DOH Certification And Inspection
If you are Level II Office Surgery Certified by the Florida DOH there will be new changes in the inspection process. Please see below communication from Cheryl White, Florida Risk Manager regarding the opportunity for mock inspections, given the new format for certification. Additionally, see attachment.
Dear Office Surgery Administrator,
We would like to offer a Pre-Inspection Consultation prior to your next Office-Based Surgery Inspection. Big Changes have occurred! We are no longer state inspectors. The State of Florida has changed the Office Based Surgery program inspectors. The new inspectors will be from the Investigative Services Unit.
Please see the attached document that shows what we can do to help your office get ready.
Cheryl E. White, RN, BS, MSHL, LNCC, LHRM, MSCC, DFSHRMPS
Sheree M. Saroff, RN, BSN, MBA, LHRM, CLC, MSCC
Harold Cordner, MD
The use of opioids to treat acute and chronic nonmalignant and malignant pain has steadily increased since the late 1990s. With this increase in opioid use, prescription opioid abuse increased to epidemic proportions. In 2012, an estimated 2.1 million Americans suffered through substance-abuse problems related to prescription opioid pain relievers. Florida was the epicenter of prescription-drug abuse, overdose deaths and "pill mills."
Since 2010, the state of Florida has drastically reduced the accidental deaths due to prescription opioid abuse through legislation, the enactment of the Prescription Drug Monitoring Program, the crackdown on pill mills and other means.
FSIPP President Harold L Dalton, DO in attendance.
DEERFIELD BEACH, Fla. —Fear of the DEA has been a recurring theme in the WESH 2 News ongoing investigation of Florida's prescription drug problem. Patients with real health issues are being denied the medication.
The DEA said it would answer those accusations at Florida's Board of Pharmacy hearing Monday.
"We don't want people to fear us, ...
Articles on Genetics Testing in Pain Management
Reserved for those who donate to the FSIPP PAC or to FSIPP.
Our parent organization is ASIPP, the American Society of Interventional Pain Physicians. Visit ASIPPs website, for a bountiful resource for pain practitioners, and to review a list of ASIPPs accomplishments which have greatly benefited both pain patients and pain physicians.